Global Human Microbiome Market

Global Human Microbiome Market
Report Id
HCNLS-2AA0FD7
Publishing Date
September 2019
Number of Pages
156
Available Formats
Global Human Microbiome Market

360iResearch predicts the Global Human Microbiome Market to grow from USD 614.58 Millions in 2018 to USD 2506.87 Millions by 2025, at a Compound Annual Growth Rate (CAGR) of 22.24%. The year 2018 has been considered as the base year, while the forecast period is up to 2025.

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Company Usability Profiles:

The Global Human Microbiome Market research report provides the company usability profiles and analyze the business overview, strategy, and SWOT analysis of the following company:

  • DuPont
  • E.I. Du Pont De Nemours and Company
  • Enterome Bioscience
  • Merck & Co., Inc.
  • Metabiomics Corporation
  • Microbiome Therapeutics, LLC
  • Osel, Inc.
  • Second Genome, Inc.
  • Seres Therapeutics
  • Synlogic Inc.
  • Synthetic Biologics Inc.
  • Vedanta Biosciences, Inc.
  • Vithera Pharmaceuticals
  • Yakult Honsha Co., Ltd.

Market Segmentation & Coverage:

The research report categorizes the Global Human Microbiome Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY
    • 16s rRNA Sequencing
    • Cell Culture Technology
    • Computational Tools
    • High-Throughput Technology
    • Metagenomic Sequencing
    • Omics Technology
  • GLOBAL HUMAN MICROBIOME MARKET, BY THERAPEUTIC AREA
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Skin Disorders
    • Women’s Health
  • GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT
    • Diagnostic Devices
    • Drugs
    • Foods
    • Medical Foods
    • Prebiotics
    • Probiotics
  • GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE
    • Acute Diarrhea
    • Autoimmune Disorders
    • Cancer
    • Diabetes
    • Mental Disorders
    • Obesity
  • GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION
    • Diagnostics
    • Therapeutics
  • GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY
    • Americas
      • Canada
      • Mexico
      • United States
    • Asia-Pacific
      • China
      • India
      • Japan
    • Europe, Middle East & Africa
      • France
      • Germany
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Human Microbiome Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Human Microbiome Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Human Microbiome Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Human Microbiome Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Human Microbiome Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Human Microbiome Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Human Microbiome Market .
  • Evaluate the key vendors in the Global Human Microbiome Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
    3. Research Outcome
      1. 360iResearch Competitive Strategic Window
        1. Leverage Zone
        2. Vantage Zone
        3. Speculative Zone
        4. Bottleneck Zone
      2. 360iResearch FPNV Positioning Matrix
        1. 360iResearch Quadrants
          1. Forefront
          2. Pathfinders
          3. Niche
          4. Vital
        2. Business Strategy
          1. Business Growth
          2. Industry Coverage
          3. Financial Viability
          4. Channel Support
        3. Product Satisfaction
          1. Value for Money
          2. Ease of Use
          3. Product Features
          4. Customer Support
  3. Executive Summary
    1. Outlook in the Human Microbiome Market
    2. Opportunities in the Human Microbiome Market
    3. Geographical Analysis in the Human Microbiome Market
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Increased focus on human microbiome therapy
        2. Human microbiome for drug development, early disease detection, and diagnosis
      2. Restraints
        1. Limited expertise and lack of comprehensive research
      3. Opportunities
        1. Increasing collaborations and research investments to create growth opportunities
        2. Development of human microbiome therapeutic products
      4. Challenges
        1. Causal links between microbiota dysbiosis and disease
    3. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Industry Trends
      1. Regulatory Framework
      2. Patent & Funding
      3. Impact of Human Microbiome Therapeutics on Current Treatment Options
  5. Global Human Microbiome Market, by Technology
    1. Overview
    2. Market Sizing & Forecasting
    3. 16s rRNA Sequencing
    4. Cell Culture Technology
    5. Computational Tools
    6. High-Throughput Technology
    7. Metagenomic Sequencing
    8. Omics Technology
  6. Global Human Microbiome Market, by Therapeutic Area
    1. Overview
    2. Market Sizing & Forecasting
    3. Gastrointestinal Disorders
    4. Metabolic Disorders
    5. Skin Disorders
    6. Women’s Health
  7. Global Human Microbiome Market, by Product
    1. Overview
    2. Market Sizing & Forecasting
    3. Diagnostic Devices
    4. Drugs
    5. Foods
    6. Medical Foods
    7. Prebiotics
    8. Probiotics
  8. Global Human Microbiome Market, by Disease
    1. Overview
    2. Market Sizing & Forecasting
    3. Acute Diarrhea
    4. Autoimmune Disorders
    5. Cancer
    6. Diabetes
    7. Mental Disorders
    8. Obesity
  9. Global Human Microbiome Market, by Application
    1. Overview
    2. Market Sizing & Forecasting
    3. Diagnostics
    4. Therapeutics
  10. Global Human Microbiome Market, by Geography
    1. Americas
      1. Overview
      2. Market Sizing & Forecasting
      3. Canada
      4. Mexico
      5. United States
    2. Asia-Pacific
      1. Overview
      2. Market Sizing & Forecasting
      3. China
      4. India
      5. Japan
    3. Europe, Middle East & Africa
      1. Overview
      2. Market Sizing & Forecasting
      3. France
      4. Germany
      5. United Kingdom
  11. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix for Global Human Microbiome Market
    2. Market Vendor Ranking Analysis for Global Human Microbiome Market
    3. Competitive News Feed Analysis for Global Human Microbiome Market
  12. Company Usability Profiles
    1. DuPont
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    2. E.I. Du Pont De Nemours and Company
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    3. Enterome Bioscience
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    4. Merck & Co., Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    5. Metabiomics Corporation
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    6. Microbiome Therapeutics, LLC
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    7. Osel, Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    8. Second Genome, Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    9. Seres Therapeutics
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    10. Synlogic Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    11. Synthetic Biologics Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    12. Vedanta Biosciences, Inc.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    13. Vithera Pharmaceuticals
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
    14. Yakult Honsha Co., Ltd.
      1. Overview
      2. Strategy
      3. SWOT
      4. Scorecard
  13. Appendix
    1. Discussion Guide
    2. Top Reports
      1. Global Automated Fingerprint Identification System Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      2. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      3. Global Autonomous Truck Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      4. Global Energy Security Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
    3. Author Details

List of Tables

  1. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD MILLIONS)
  2. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLIONS)
  4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLIONS)
  11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MEDICAL FOODS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLIONS)
  23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLIONS)
  30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2017-2025 (USD MILLIONS)
  32. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLIONS)
  33. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLIONS)
  34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLIONS)
  35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLIONS)
  37. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLIONS)
  38. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLIONS)
  39. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLIONS)
  40. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLIONS)
  41. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  42. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLIONS)
  43. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLIONS)
  44. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2017-2025 (USD MILLIONS)
  45. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLIONS)
  46. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLIONS)
  47. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLIONS)
  48. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLIONS)
  49. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLIONS)
  50. GLOBAL HUMAN MICROBIOME MARKET: MARKET VENDOR RANKING ANALYSIS
  51. DUPONT: FPNV SCORECARD
  52. DUPONT: BUSINESS STRATEGY
  53. DUPONT: PRODUCT SATISFACTION
  54. E.I. DU PONT DE NEMOURS AND COMPANY: FPNV SCORECARD
  55. E.I. DU PONT DE NEMOURS AND COMPANY: BUSINESS STRATEGY
  56. E.I. DU PONT DE NEMOURS AND COMPANY: PRODUCT SATISFACTION
  57. ENTEROME BIOSCIENCE: FPNV SCORECARD
  58. ENTEROME BIOSCIENCE: BUSINESS STRATEGY
  59. ENTEROME BIOSCIENCE: PRODUCT SATISFACTION
  60. MERCK & CO., INC.: FPNV SCORECARD
  61. MERCK & CO., INC.: BUSINESS STRATEGY
  62. MERCK & CO., INC.: PRODUCT SATISFACTION
  63. METABIOMICS CORPORATION: FPNV SCORECARD
  64. METABIOMICS CORPORATION: BUSINESS STRATEGY
  65. METABIOMICS CORPORATION: PRODUCT SATISFACTION
  66. MICROBIOME THERAPEUTICS, LLC: FPNV SCORECARD
  67. MICROBIOME THERAPEUTICS, LLC: BUSINESS STRATEGY
  68. MICROBIOME THERAPEUTICS, LLC: PRODUCT SATISFACTION
  69. OSEL, INC.: FPNV SCORECARD
  70. OSEL, INC.: BUSINESS STRATEGY
  71. OSEL, INC.: PRODUCT SATISFACTION
  72. SECOND GENOME, INC.: FPNV SCORECARD
  73. SECOND GENOME, INC.: BUSINESS STRATEGY
  74. SECOND GENOME, INC.: PRODUCT SATISFACTION
  75. SERES THERAPEUTICS: FPNV SCORECARD
  76. SERES THERAPEUTICS: BUSINESS STRATEGY
  77. SERES THERAPEUTICS: PRODUCT SATISFACTION
  78. SYNLOGIC INC.: FPNV SCORECARD
  79. SYNLOGIC INC.: BUSINESS STRATEGY
  80. SYNLOGIC INC.: PRODUCT SATISFACTION
  81. SYNTHETIC BIOLOGICS INC.: FPNV SCORECARD
  82. SYNTHETIC BIOLOGICS INC.: BUSINESS STRATEGY
  83. SYNTHETIC BIOLOGICS INC.: PRODUCT SATISFACTION
  84. VEDANTA BIOSCIENCES, INC.: FPNV SCORECARD
  85. VEDANTA BIOSCIENCES, INC.: BUSINESS STRATEGY
  86. VEDANTA BIOSCIENCES, INC.: PRODUCT SATISFACTION
  87. VITHERA PHARMACEUTICALS: FPNV SCORECARD
  88. VITHERA PHARMACEUTICALS: BUSINESS STRATEGY
  89. VITHERA PHARMACEUTICALS: PRODUCT SATISFACTION
  90. YAKULT HONSHA CO., LTD.: FPNV SCORECARD
  91. YAKULT HONSHA CO., LTD.: BUSINESS STRATEGY
  92. YAKULT HONSHA CO., LTD.: PRODUCT SATISFACTION
  93. GLOBAL HUMAN MICROBIOME MARKET: AUTHOR DETAILS

List of Figures

  1. Global Human Microbiome Market: Research Process
  2. Global Human Microbiome Market: Research Framework
  3. Global Human Microbiome Market: Forecasting Methodology
  4. Global Human Microbiome Market: 360iResearch Competitive Strategic Window
  5. Global Human Microbiome Market: 360iResearch FPNV Positioning Matrix
  6. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD MILLIONS)
  7. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLIONS)
  8. GLOBAL HUMAN MICROBIOME MARKET: MARKET CONNECTIVITY
  9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018 VS 2025 (USD MILLIONS)
  10. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2025 (USD MILLIONS)
  11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018 VS 2025 (USD MILLIONS)
  12. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2025 (USD MILLIONS)
  13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018 VS 2025 (USD MILLIONS)
  14. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2025 (USD MILLIONS)
  15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018 VS 2025 (USD MILLIONS)
  16. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2025 (USD MILLIONS)
  17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018 VS 2025 (USD MILLIONS)
  18. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025 (USD MILLIONS)
  19. DUPONT: BUSINESS SWOT
  20. E.I. DU PONT DE NEMOURS AND COMPANY: BUSINESS SWOT
  21. ENTEROME BIOSCIENCE: BUSINESS SWOT
  22. MERCK & CO., INC.: BUSINESS SWOT
  23. METABIOMICS CORPORATION: BUSINESS SWOT
  24. MICROBIOME THERAPEUTICS, LLC: BUSINESS SWOT
  25. OSEL, INC.: BUSINESS SWOT
  26. SECOND GENOME, INC.: BUSINESS SWOT
  27. SERES THERAPEUTICS: BUSINESS SWOT
  28. SYNLOGIC INC.: BUSINESS SWOT
  29. SYNTHETIC BIOLOGICS INC.: BUSINESS SWOT
  30. VEDANTA BIOSCIENCES, INC.: BUSINESS SWOT
  31. VITHERA PHARMACEUTICALS: BUSINESS SWOT
  32. YAKULT HONSHA CO., LTD.: BUSINESS SWOT

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy Policy
Payment Card Industry Data Security StandardGeneral Data Protection Regulation